Examining correlations between opioid dispensing and opioid-related hospitalizations in Canada, 2007-2016

BMC Health Services Research
Wayne JonesBenedikt Fischer

Abstract

High levels of opioid-related mortality, as well as morbidity, contribute to the excessive opioid-related disease burden in North America, induced by high availability of opioids. While correlations between opioid dispensing levels and mortality outcomes are well-established, fewer evidence exists on correlations with morbidity (e.g., hospitalizations). We examined possible overtime correlations between medical opioid dispensing and opioid-related hospitalizations in Canada, by province, 2007-2016. For dispensing, we examined annual volumes of medical opioid dispensing derived from a representative, stratified sample of retail pharmacies across Canada. Raw dispensing information for 'strong opioids' was converted into Defined Daily Doses per 1000 population per day (DDD/1000/day). Opioid-related hospitalization rates referred to opioid poisoning-related admissions by province, for fiscal years 2007-08 to 2016-17, drawn from the national Hospital Morbidity Database. We assessed possible correlations between opioid dispensing and hospitalizations by province using the Pearson product moment correlation; correlation values (r) and confidence intervals were reported. Significant correlations for overtime correlations between popula...Continue Reading

References

Jun 17, 2008·Journal of Addictive Diseases·Angela M WisniewskiRichard D Blondell
Feb 13, 2013·Drug and Alcohol Dependence·F ModaraiL Paulozzi
Jan 5, 2014·Journal of Clinical Pharmacy and Therapeutics·R B Raffa, J V Pergolizzi
Jun 26, 2014·British Journal of Clinical Pharmacology·Bianca BlanchPaul S Haber
Jul 22, 2014·Addiction·Tara GomesDavid N Juurlink
Jan 13, 2015·Annual Review of Public Health·Andrew KolodnyG Caleb Alexander
Mar 16, 2016·JAMA : the Journal of the American Medical Association·Deborah DowellRoger Chou
Sep 15, 2016·Australian and New Zealand Journal of Public Health·Janneke Berecki-GisolfRoderick McClure
Nov 9, 2016·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Benedikt FischerMark Tyndall
Jan 20, 2017·Pharmacoepidemiology and Drug Safety·Suzanne NielsenLouisa Degenhardt
May 10, 2017·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Jason W BusseGordon H Guyatt
Jul 7, 2017·MMWR. Morbidity and Mortality Weekly Report·Gery P GuyDeborah Dowell
Jul 10, 2017·The International Journal on Drug Policy·George Jay Unick, Daniel Ciccarone
Oct 5, 2017·JAMA : the Journal of the American Medical Association·Deborah DowellGrant Baldwin
Oct 19, 2017·Neuropharmacology·Patil ArmenianKara L Lynch
Oct 31, 2017·The Cochrane Database of Systematic Reviews·Charl ElsSebastian Straube
Jun 19, 2018·Health Promotion and Chronic Disease Prevention in Canada·Lisa Belzak, Jessica Halverson
Jul 28, 2018·European Journal of Pain : EJP·C ChenafN Authier
Dec 24, 2018·The Lancet. Public Health·Benedikt FischerMark Tyndall
Jan 16, 2019·JAMA Network Open·Tara GomesDavid N Juurlink
Apr 24, 2019·Canada Communicable Disease Report = Relevé Des Maladies Transmissibles Au Canada·D SchanzerJ Feld

❮ Previous
Next ❯

Citations

Aug 12, 2020·Nursing Philosophy : an International Journal for Healthcare Professionals·Thomas Foth
Jan 28, 2021·Substance Abuse Treatment, Prevention, and Policy·Lucas O MaiaBenedikt Fischer
Feb 17, 2021·Substance Abuse Treatment, Prevention, and Policy·Benedikt FischerDimitri Daldegan-Bueno

❮ Previous
Next ❯

Software Mentioned

R stats package

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.